Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer. (29th April 2020)
- Record Type:
- Journal Article
- Title:
- Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer. (29th April 2020)
- Main Title:
- Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer
- Authors:
- Kunimasa, Kei
Hirotsu, Yosuke
Amemiya, Kenji
Nagakubo, Yuki
Goto, Taichiro
Miyashita, Yoshihiro
Kakizaki, Yumiko
Tsutsui, Toshiharu
Otake, Sotaro
Kobayashi, Hiroaki
Higuchi, Rumi
Inomata, Kie
Kumagai, Takashi
Mochizuki, Hitoshi
Nakamura, Harumi
Nakatsuka, Shin‐ichi
Nishino, Kazumi
Imamura, Fumio
Kumagai, Toru
Oyama, Toshio
Omata, Masao - Abstract:
- Abstract: Introductions: When tumor tissue samples are unavailable to search for actionable driver mutations, archival cytology samples can be useful. We investigate whether archival cytology samples can yield reliable genomic information compared to corresponding formalin‐fixed paraffin‐embedded (FFPE) tumor samples. Patients and Methods: Pretreatment class V archival cytology samples with adequate tumor cells were selected from 172 lung cancer patients. The genomic profiles of the primary lung tumors have been analyzed through whole‐exome regions of 53 genes. We compared the genomic profiles based on the oncogenicity and variant allele frequency (VAF) between the archival cytology and the corresponding primary tumors. We also analyzed the genomic profiles of serial cytological samples during the treatment of EGFR‐TKI. Results: A total of 43 patients were analyzed with the paired samples for DNA mutations and other three patients were analyzed for their fusion genes. A total of 672 mutations were detected. Of those, 106 mutations (15.8%) were shared with both samples. Sixty of seventy‐seven (77.9%) shared mutations were oncogenic or likely oncogenic mutations with VAF ≧10%. As high as 90% (9/10) actionable driver mutations and ALK and ROS1 fusion genes were successfully detected from archival cytology samples. Sequential analysis revealed the dynamic changes in EGFR‐TKI‐resistant mutation ( EGFR p.T790M) during the course of treatment. Conclusion: Archival cytology sampleAbstract: Introductions: When tumor tissue samples are unavailable to search for actionable driver mutations, archival cytology samples can be useful. We investigate whether archival cytology samples can yield reliable genomic information compared to corresponding formalin‐fixed paraffin‐embedded (FFPE) tumor samples. Patients and Methods: Pretreatment class V archival cytology samples with adequate tumor cells were selected from 172 lung cancer patients. The genomic profiles of the primary lung tumors have been analyzed through whole‐exome regions of 53 genes. We compared the genomic profiles based on the oncogenicity and variant allele frequency (VAF) between the archival cytology and the corresponding primary tumors. We also analyzed the genomic profiles of serial cytological samples during the treatment of EGFR‐TKI. Results: A total of 43 patients were analyzed with the paired samples for DNA mutations and other three patients were analyzed for their fusion genes. A total of 672 mutations were detected. Of those, 106 mutations (15.8%) were shared with both samples. Sixty of seventy‐seven (77.9%) shared mutations were oncogenic or likely oncogenic mutations with VAF ≧10%. As high as 90% (9/10) actionable driver mutations and ALK and ROS1 fusion genes were successfully detected from archival cytology samples. Sequential analysis revealed the dynamic changes in EGFR‐TKI‐resistant mutation ( EGFR p.T790M) during the course of treatment. Conclusion: Archival cytology sample with adequate tumor cells can yield genetic information compared to the primary tumors. If tumor tissue samples are unavailable, we can use archival cytology samples to search for actionable driver mutations. Abstract : Limited quantity of tumor tissue is a matter to obtain full genomic information in lung cancer. Archival cytology samples can yield genetic information of the correspondent primary tumor. 90% targetable driver mutations were successfully detected from archival cytology samples. … (more)
- Is Part Of:
- Cancer medicine. Volume 9:Number 13(2020)
- Journal:
- Cancer medicine
- Issue:
- Volume 9:Number 13(2020)
- Issue Display:
- Volume 9, Issue 13 (2020)
- Year:
- 2020
- Volume:
- 9
- Issue:
- 13
- Issue Sort Value:
- 2020-0009-0013-0000
- Page Start:
- 4501
- Page End:
- 4511
- Publication Date:
- 2020-04-29
- Subjects:
- cytology -- driver mutation -- fusion gene -- lung cancer -- next‐generation sequence
616.994005 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634 ↗ - DOI:
- 10.1002/cam4.3089 ↗
- Languages:
- English
- ISSNs:
- 2045-7634
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13353.xml